Revisit - BUZZ - Preview: PepsiCo expected to report flat earnings per share, investors focus on consumer spending
路透社2026/10/08 09:06Republishing the BUZZ report released on Wednesday without modification: October 8 - PepsiCo (PEP.O) shares fell 1.4% on Wednesday, closing at $124.02. The company is set to release its quarterly earnings before the market opens on Thursday, with investors closely watching whether tighter consumer budgets are exerting pressure. According to data from London Stock Exchange Group (LSEG), Wall Street expects the carbonated drinks and snack giant’s third-quarter revenue to rise about 4% year-over-year to $24.96 billion, with adjusted earnings per share (EPS) at $2.29, flat compared to the same period last year. In the previous quarter, PEP’s revenue exceeded expectations, but the company warned that performance in North America would slow due to tighter consumer budgets. Facing cost pressures and the threat from GLP-1 weight loss drugs, PepsiCo is running out of time to meet the growth and profit margin targets set after activist investor Elliott Management invested approximately $4 billion a year ago. (link) So far this year, PEP’s share price has fallen about 14%, underperforming the S&P 500 Soft Drinks & Non-alcoholic Beverages Index (.SPLRCBEVS), which is up about 8%, and the S&P 500 Consumer Staples Index (.SPLRCS), up 6%. The stock’s recent price-earnings ratio is 14, below its five-year average of 21. Among 25 analysts, 7 recommend “strong buy” or “buy”, 17 recommend “hold”, and 1 recommends “sell”. The median target price is $152, down from $170 on July 7. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may be inaccurate or may not capture the required context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for readers’ convenience. Reuters accepts no liability for any damage or loss caused by the use of the automated translation feature.)
Republished Wednesday's BUZZ report, content unchanged
October 8 - ** PepsiCo (PEP.O) shares fell 1.4% on Wednesday, closing at $124.02. The company is set to report quarterly results before the open on Thursday, as investors closely watch whether tightening consumer budgets are creating pressure
** According to London Stock Exchange Group (LSEG) data, Wall Street expects the soft drink and snack giant's third-quarter revenue to rise about 4% year-on-year to $24.96 billion, and adjusted earnings per share (EPS) at $2.29, flat with the same period last year
** In the previous quarter, PEP’s revenue topped expectations but it warned that tightening consumer budgets would lead to a slowdown in North America’s performance
** Facing cost pressures and the threat from GLP-1 weight loss drugs, time is running out for PepsiCo (PEP) to deliver on its growth and profit margin goals set after activist investor Elliott Management took a roughly $4 billion stake a year ago (link)
** Year-to-date, PEP's share price has fallen about 14%, underperforming the S&P 500 Soft Drinks & Non-Alcoholic Beverages Index, which is up about 8% .SPLRCBEVS, and the S&P 500 Consumer Staples Index, up 6% .SPLRCS
** The stock's recent price-to-earnings ratio stands at 14 times, below its five-year average of 21 times
** Of 25 analysts, 7 recommend “strong buy” or “buy,” 17 recommend “hold,” and 1 recommends “sell.” The median target price is $152, down from $170 on July 7
(To assist non-native English speakers, Reuters provides automated translations of its reports in several other languages. Because automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of these translated texts and provides them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss resulting from use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley senior bond investor turns bullish on US Treasuries for the first time in ten years
US Stock Movement | SuperX AI Technology (SUPX.US) once fell more than 2.5%, hitting an intraday low of $6.46
SuperX AI Technology's stock price declined, falling more than 2.5% at one point.
BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars
Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)
Crypto prices
More
